Hanlon J T, Schmader K E, Landerman L R, Horner R D, Fillenbaum G G, Pieper C F, Wall W E, Koronkowski M J, Cohen H J
Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, NC 27710, USA.
Ann Epidemiol. 1997 Feb;7(2):87-94. doi: 10.1016/s1047-2797(96)00124-x.
To evaluate the relationship of nonsteroidal antiinflammatory drug (NSAID) use to level of cognitive function in community-dwelling elderly persons.
The prospective cohort study included 2765 nonproxy subjects from the Duke University Established Populations for Epidemiologic Studies of the Elderly who were cognitively intact at baseline (1986-1987) and alive at follow-up three year later. Cognitive function was assessed by the Short Portable Mental Status Questionnaire (i.e., intact vs. impaired and change in score) and by the individual domains of the Orientation-Memory-Concentration Test (i.e., number of errors). NSAID use, determined from in-home interviews, was coded for chronicity, dose, frequency of use, and prescription status.
After controlling for demographic factors as well as health status and behavior, continuous, regularly-scheduled, prescription use of NSAID was associated with preservation of one aspect of cognitive functioning: concentration (beta coefficient, 0.29; 95% confidence interval [CI] -0.54 to -0.04, indicating fewer errors). However, no consistent dose-response relationship was found. Current and prior NSAID use was unrelated to level of cognitive functioning across all five measures; among current users, those taking moderate or high doses (beta coefficient, 0.41; 95% CI, 0.08 to 0.74) made more errors on the memory test compared with those taking low doses (beta coefficient 0.03; 95% CI, -.85 to 0.91).
These results suggest no substantial or consistent protective effect of prescription NSAID use on cognitive function in community-dwelling elderly. However, recent use at higher doses may be associated with memory deterioration in this population.
评估非甾体抗炎药(NSAID)的使用与社区居住老年人认知功能水平之间的关系。
这项前瞻性队列研究纳入了来自杜克大学老年流行病学研究既定人群的2765名非代理人受试者,他们在基线时(1986 - 1987年)认知功能完好,且在三年后的随访中仍存活。认知功能通过简短便携式精神状态问卷(即完好与受损以及分数变化)和定向 - 记忆 - 注意力测试的各个领域(即错误数量)进行评估。通过家庭访谈确定的NSAID使用情况,根据慢性程度、剂量、使用频率和处方状态进行编码。
在控制了人口统计学因素以及健康状况和行为后,持续、定期、处方使用NSAID与认知功能的一个方面的保留有关:注意力(β系数,0.29;95%置信区间[CI] -0.54至 -0.04,表明错误较少)。然而,未发现一致的剂量 - 反应关系。当前和既往使用NSAID与所有五项测量的认知功能水平均无关;在当前使用者中,与低剂量使用者相比,服用中高剂量(β系数,0.41;95% CI,0.08至0.74)的人在记忆测试中错误更多(β系数0.03;95% CI, -0.85至0.91)。
这些结果表明,处方NSAID的使用对社区居住老年人的认知功能没有实质性或一致的保护作用。然而,近期高剂量使用可能与该人群的记忆衰退有关。